Medical research has become an enormous enterprise in the United States. The federal government spent approximately 20 billion dollars in 2001 on it, and private industry spent even more: in the range of $30 billion. The pharmaceutical industry's share of investment in biomedical research and development, now approximately 60%, has doubled since 1980. Today, approximately one-quarter of academic biomedical researchers receive industry funding. This chapter discusses how competing financial interests can hurt research subjects, embarrass researchers, and severely damage an institution's reputation. Even one or two widely publicized research fiascos involving financial conflicts can spoil the trust of the public in the entire research enterprise. It goes without saying that without the trust of the public, clinical research could not proceed.